nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivacaftor—ALB—hematologic cancer	0.143	0.512	CbGaD
Ivacaftor—ABCB1—hematologic cancer	0.137	0.488	CbGaD
Ivacaftor—ORM1—Imatinib—hematologic cancer	0.0538	0.11	CbGbCtD
Ivacaftor—ABCB1—Lenalidomide—hematologic cancer	0.0264	0.0537	CbGbCtD
Ivacaftor—ALB—Imatinib—hematologic cancer	0.0226	0.0461	CbGbCtD
Ivacaftor—CYP3A4—Bexarotene—hematologic cancer	0.0158	0.0322	CbGbCtD
Ivacaftor—ABCB1—Daunorubicin—hematologic cancer	0.0155	0.0315	CbGbCtD
Ivacaftor—ABCB1—Alitretinoin—hematologic cancer	0.0151	0.0309	CbGbCtD
Ivacaftor—ALB—Prednisone—hematologic cancer	0.0149	0.0304	CbGbCtD
Ivacaftor—CYP3A4—Busulfan—hematologic cancer	0.0147	0.0299	CbGbCtD
Ivacaftor—CYP3A4—Lomustine—hematologic cancer	0.0147	0.0299	CbGbCtD
Ivacaftor—ALB—Irinotecan—hematologic cancer	0.0141	0.0288	CbGbCtD
Ivacaftor—CYP3A4—Thiotepa—hematologic cancer	0.0131	0.0267	CbGbCtD
Ivacaftor—ABCB1—Imatinib—hematologic cancer	0.0118	0.0241	CbGbCtD
Ivacaftor—ABCB1—Nilotinib—hematologic cancer	0.0108	0.0219	CbGbCtD
Ivacaftor—ABCB1—Vinorelbine—hematologic cancer	0.0107	0.0217	CbGbCtD
Ivacaftor—CYP3A4—Methoxsalen—hematologic cancer	0.0102	0.0207	CbGbCtD
Ivacaftor—CYP3A4—Bortezomib—hematologic cancer	0.00968	0.0197	CbGbCtD
Ivacaftor—ABCB1—Dasatinib—hematologic cancer	0.00951	0.0194	CbGbCtD
Ivacaftor—ABCB1—Mitoxantrone—hematologic cancer	0.00939	0.0191	CbGbCtD
Ivacaftor—CYP3A4—Daunorubicin—hematologic cancer	0.00926	0.0189	CbGbCtD
Ivacaftor—ABCB1—Betamethasone—hematologic cancer	0.00837	0.0171	CbGbCtD
Ivacaftor—ABCB1—Gemcitabine—hematologic cancer	0.00829	0.0169	CbGbCtD
Ivacaftor—ABCB1—Prednisolone—hematologic cancer	0.00826	0.0168	CbGbCtD
Ivacaftor—CYP3A4—Cytarabine—hematologic cancer	0.00817	0.0166	CbGbCtD
Ivacaftor—CYP3A4—Teniposide—hematologic cancer	0.00804	0.0164	CbGbCtD
Ivacaftor—ABCB1—Prednisone—hematologic cancer	0.0078	0.0159	CbGbCtD
Ivacaftor—ALB—Methotrexate—hematologic cancer	0.00748	0.0152	CbGbCtD
Ivacaftor—CYP3A4—Ifosfamide—hematologic cancer	0.00742	0.0151	CbGbCtD
Ivacaftor—ABCB1—Irinotecan—hematologic cancer	0.00739	0.0151	CbGbCtD
Ivacaftor—CYP3A4—Imatinib—hematologic cancer	0.00709	0.0145	CbGbCtD
Ivacaftor—CYP3A4—Ruxolitinib—hematologic cancer	0.00668	0.0136	CbGbCtD
Ivacaftor—ABCB1—Vinblastine—hematologic cancer	0.00657	0.0134	CbGbCtD
Ivacaftor—ABCB1—Vincristine—hematologic cancer	0.00646	0.0132	CbGbCtD
Ivacaftor—CYP3A4—Nilotinib—hematologic cancer	0.00644	0.0131	CbGbCtD
Ivacaftor—CYP3A4—Vinorelbine—hematologic cancer	0.00639	0.013	CbGbCtD
Ivacaftor—ABCB1—Cisplatin—hematologic cancer	0.00603	0.0123	CbGbCtD
Ivacaftor—ABCB1—Etoposide—hematologic cancer	0.00592	0.0121	CbGbCtD
Ivacaftor—CYP3A4—Triamcinolone—hematologic cancer	0.00584	0.0119	CbGbCtD
Ivacaftor—CYP3A4—Dasatinib—hematologic cancer	0.0057	0.0116	CbGbCtD
Ivacaftor—CYP3A4—Mitoxantrone—hematologic cancer	0.00563	0.0115	CbGbCtD
Ivacaftor—CYP3A4—Betamethasone—hematologic cancer	0.00501	0.0102	CbGbCtD
Ivacaftor—CYP3A4—Prednisolone—hematologic cancer	0.00495	0.0101	CbGbCtD
Ivacaftor—ABCB1—Dexamethasone—hematologic cancer	0.00487	0.00992	CbGbCtD
Ivacaftor—CYP3A4—Prednisone—hematologic cancer	0.00467	0.00953	CbGbCtD
Ivacaftor—CYP3A4—Irinotecan—hematologic cancer	0.00443	0.00903	CbGbCtD
Ivacaftor—ABCB1—Doxorubicin—hematologic cancer	0.00404	0.00823	CbGbCtD
Ivacaftor—CYP3A4—Vinblastine—hematologic cancer	0.00394	0.00803	CbGbCtD
Ivacaftor—ABCB1—Methotrexate—hematologic cancer	0.00391	0.00798	CbGbCtD
Ivacaftor—CYP3A4—Vincristine—hematologic cancer	0.00387	0.00789	CbGbCtD
Ivacaftor—CYP3A4—Etoposide—hematologic cancer	0.00355	0.00723	CbGbCtD
Ivacaftor—CYP3A4—Dexamethasone—hematologic cancer	0.00292	0.00595	CbGbCtD
Ivacaftor—CFTR—hematopoietic system—hematologic cancer	0.00261	0.169	CbGeAlD
Ivacaftor—CYP3A4—Doxorubicin—hematologic cancer	0.00242	0.00493	CbGbCtD
Ivacaftor—CFTR—blood—hematologic cancer	0.00173	0.112	CbGeAlD
Ivacaftor—CFTR—lung—hematologic cancer	0.00152	0.0981	CbGeAlD
Ivacaftor—CFTR—testis—hematologic cancer	0.00143	0.0926	CbGeAlD
Ivacaftor—ORM1—hematopoietic system—hematologic cancer	0.00133	0.0858	CbGeAlD
Ivacaftor—ORM1—blood—hematologic cancer	0.000878	0.0568	CbGeAlD
Ivacaftor—ORM1—bone marrow—hematologic cancer	0.00085	0.055	CbGeAlD
Ivacaftor—ORM1—lung—hematologic cancer	0.00077	0.0498	CbGeAlD
Ivacaftor—ALB—testis—hematologic cancer	0.000637	0.0412	CbGeAlD
Ivacaftor—CYP3A4—hematopoietic system—hematologic cancer	0.000553	0.0358	CbGeAlD
Ivacaftor—ORM1—lymph node—hematologic cancer	0.000527	0.0341	CbGeAlD
Ivacaftor—ALB—lymph node—hematologic cancer	0.000462	0.0299	CbGeAlD
Ivacaftor—ABCB1—hematopoietic system—hematologic cancer	0.000392	0.0253	CbGeAlD
Ivacaftor—CYP3A4—blood—hematologic cancer	0.000367	0.0237	CbGeAlD
Ivacaftor—ABCB1—gonad—hematologic cancer	0.000298	0.0193	CbGeAlD
Ivacaftor—ABCB1—blood—hematologic cancer	0.000259	0.0168	CbGeAlD
Ivacaftor—ABCB1—bone marrow—hematologic cancer	0.000251	0.0162	CbGeAlD
Ivacaftor—ABCB1—lung—hematologic cancer	0.000227	0.0147	CbGeAlD
Ivacaftor—ABCB1—testis—hematologic cancer	0.000215	0.0139	CbGeAlD
Ivacaftor—ABCB1—lymph node—hematologic cancer	0.000156	0.0101	CbGeAlD
Ivacaftor—Diarrhoea—Hydroxyurea—hematologic cancer	9.71e-05	0.000541	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Ifosfamide—hematologic cancer	9.7e-05	0.000541	CcSEcCtD
Ivacaftor—Nausea—Cladribine—hematologic cancer	9.64e-05	0.000537	CcSEcCtD
Ivacaftor—Infection—Cisplatin—hematologic cancer	9.62e-05	0.000537	CcSEcCtD
Ivacaftor—Hypoglycaemia—Doxorubicin—hematologic cancer	9.59e-05	0.000535	CcSEcCtD
Ivacaftor—Dizziness—Lenalidomide—hematologic cancer	9.52e-05	0.000531	CcSEcCtD
Ivacaftor—Nervous system disorder—Cisplatin—hematologic cancer	9.5e-05	0.00053	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Gemcitabine—hematologic cancer	9.46e-05	0.000528	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Vincristine—hematologic cancer	9.45e-05	0.000527	CcSEcCtD
Ivacaftor—Abdominal pain—Thalidomide—hematologic cancer	9.44e-05	0.000527	CcSEcCtD
Ivacaftor—Skin disorder—Cisplatin—hematologic cancer	9.41e-05	0.000525	CcSEcCtD
Ivacaftor—Dizziness—Hydroxyurea—hematologic cancer	9.38e-05	0.000523	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Carmustine—hematologic cancer	9.38e-05	0.000523	CcSEcCtD
Ivacaftor—Rash—Melphalan—hematologic cancer	9.33e-05	0.00052	CcSEcCtD
Ivacaftor—Dermatitis—Melphalan—hematologic cancer	9.32e-05	0.00052	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Alitretinoin—hematologic cancer	9.29e-05	0.000518	CcSEcCtD
Ivacaftor—Nausea—Vinblastine—hematologic cancer	9.24e-05	0.000515	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Irinotecan—hematologic cancer	9.21e-05	0.000513	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	9.19e-05	0.000513	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Ifosfamide—hematologic cancer	9.18e-05	0.000512	CcSEcCtD
Ivacaftor—Breast disorder—Epirubicin—hematologic cancer	9.14e-05	0.00051	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Epirubicin—hematologic cancer	9.11e-05	0.000508	CcSEcCtD
Ivacaftor—Rash—Lenalidomide—hematologic cancer	9.07e-05	0.000506	CcSEcCtD
Ivacaftor—Abdominal pain—Carmustine—hematologic cancer	9.07e-05	0.000506	CcSEcCtD
Ivacaftor—Dermatitis—Lenalidomide—hematologic cancer	9.07e-05	0.000506	CcSEcCtD
Ivacaftor—Diarrhoea—Bortezomib—hematologic cancer	9.06e-05	0.000505	CcSEcCtD
Ivacaftor—Nasopharyngitis—Epirubicin—hematologic cancer	9.05e-05	0.000505	CcSEcCtD
Ivacaftor—Headache—Lenalidomide—hematologic cancer	9.02e-05	0.000503	CcSEcCtD
Ivacaftor—Abdominal pain—Alitretinoin—hematologic cancer	8.98e-05	0.000501	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Gemcitabine—hematologic cancer	8.97e-05	0.0005	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Vincristine—hematologic cancer	8.95e-05	0.000499	CcSEcCtD
Ivacaftor—Rash—Hydroxyurea—hematologic cancer	8.95e-05	0.000499	CcSEcCtD
Ivacaftor—Dermatitis—Hydroxyurea—hematologic cancer	8.94e-05	0.000499	CcSEcCtD
Ivacaftor—Headache—Hydroxyurea—hematologic cancer	8.89e-05	0.000496	CcSEcCtD
Ivacaftor—Abdominal pain—Ifosfamide—hematologic cancer	8.88e-05	0.000495	CcSEcCtD
Ivacaftor—Diarrhoea—Vinorelbine—hematologic cancer	8.85e-05	0.000493	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Cisplatin—hematologic cancer	8.82e-05	0.000492	CcSEcCtD
Ivacaftor—Infection—Etoposide—hematologic cancer	8.81e-05	0.000492	CcSEcCtD
Ivacaftor—Connective tissue disorder—Prednisone—hematologic cancer	8.79e-05	0.00049	CcSEcCtD
Ivacaftor—Nausea—Melphalan—hematologic cancer	8.79e-05	0.00049	CcSEcCtD
Ivacaftor—Dizziness—Bortezomib—hematologic cancer	8.76e-05	0.000488	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Mitoxantrone—hematologic cancer	8.72e-05	0.000486	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Irinotecan—hematologic cancer	8.72e-05	0.000486	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Methotrexate—hematologic cancer	8.68e-05	0.000484	CcSEcCtD
Ivacaftor—Abdominal pain—Vincristine—hematologic cancer	8.66e-05	0.000483	CcSEcCtD
Ivacaftor—Skin disorder—Etoposide—hematologic cancer	8.62e-05	0.000481	CcSEcCtD
Ivacaftor—Dizziness—Vinorelbine—hematologic cancer	8.55e-05	0.000477	CcSEcCtD
Ivacaftor—Nausea—Lenalidomide—hematologic cancer	8.55e-05	0.000477	CcSEcCtD
Ivacaftor—Breast disorder—Doxorubicin—hematologic cancer	8.46e-05	0.000472	CcSEcCtD
Ivacaftor—Diarrhoea—Thiotepa—hematologic cancer	8.45e-05	0.000471	CcSEcCtD
Ivacaftor—Abdominal pain—Irinotecan—hematologic cancer	8.43e-05	0.00047	CcSEcCtD
Ivacaftor—Abdominal pain—Mitoxantrone—hematologic cancer	8.43e-05	0.00047	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Doxorubicin—hematologic cancer	8.43e-05	0.00047	CcSEcCtD
Ivacaftor—Nausea—Hydroxyurea—hematologic cancer	8.43e-05	0.00047	CcSEcCtD
Ivacaftor—Myalgia—Triamcinolone—hematologic cancer	8.39e-05	0.000468	CcSEcCtD
Ivacaftor—Nasopharyngitis—Doxorubicin—hematologic cancer	8.37e-05	0.000467	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Cisplatin—hematologic cancer	8.36e-05	0.000466	CcSEcCtD
Ivacaftor—Rash—Bortezomib—hematologic cancer	8.35e-05	0.000466	CcSEcCtD
Ivacaftor—Dermatitis—Bortezomib—hematologic cancer	8.34e-05	0.000465	CcSEcCtD
Ivacaftor—Infestation NOS—Methotrexate—hematologic cancer	8.33e-05	0.000465	CcSEcCtD
Ivacaftor—Infestation—Methotrexate—hematologic cancer	8.33e-05	0.000465	CcSEcCtD
Ivacaftor—Headache—Bortezomib—hematologic cancer	8.3e-05	0.000463	CcSEcCtD
Ivacaftor—Rash—Bleomycin—hematologic cancer	8.29e-05	0.000462	CcSEcCtD
Ivacaftor—Dermatitis—Bleomycin—hematologic cancer	8.28e-05	0.000462	CcSEcCtD
Ivacaftor—Diarrhoea—Thalidomide—hematologic cancer	8.17e-05	0.000456	CcSEcCtD
Ivacaftor—Dizziness—Thiotepa—hematologic cancer	8.17e-05	0.000455	CcSEcCtD
Ivacaftor—Rash—Vinorelbine—hematologic cancer	8.15e-05	0.000455	CcSEcCtD
Ivacaftor—Dermatitis—Vinorelbine—hematologic cancer	8.15e-05	0.000454	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Epirubicin—hematologic cancer	8.13e-05	0.000453	CcSEcCtD
Ivacaftor—Headache—Vinorelbine—hematologic cancer	8.1e-05	0.000452	CcSEcCtD
Ivacaftor—Infection—Triamcinolone—hematologic cancer	7.99e-05	0.000446	CcSEcCtD
Ivacaftor—Dizziness—Thalidomide—hematologic cancer	7.9e-05	0.000441	CcSEcCtD
Ivacaftor—Nausea—Bortezomib—hematologic cancer	7.87e-05	0.000439	CcSEcCtD
Ivacaftor—Diarrhoea—Carmustine—hematologic cancer	7.85e-05	0.000438	CcSEcCtD
Ivacaftor—Nausea—Bleomycin—hematologic cancer	7.81e-05	0.000435	CcSEcCtD
Ivacaftor—Infestation NOS—Epirubicin—hematologic cancer	7.8e-05	0.000435	CcSEcCtD
Ivacaftor—Infestation—Epirubicin—hematologic cancer	7.8e-05	0.000435	CcSEcCtD
Ivacaftor—Rash—Thiotepa—hematologic cancer	7.79e-05	0.000434	CcSEcCtD
Ivacaftor—Dermatitis—Thiotepa—hematologic cancer	7.78e-05	0.000434	CcSEcCtD
Ivacaftor—Diarrhoea—Alitretinoin—hematologic cancer	7.78e-05	0.000434	CcSEcCtD
Ivacaftor—Headache—Thiotepa—hematologic cancer	7.74e-05	0.000431	CcSEcCtD
Ivacaftor—Diarrhoea—Ifosfamide—hematologic cancer	7.68e-05	0.000429	CcSEcCtD
Ivacaftor—Nausea—Vinorelbine—hematologic cancer	7.68e-05	0.000428	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Etoposide—hematologic cancer	7.66e-05	0.000427	CcSEcCtD
Ivacaftor—Myalgia—Betamethasone—hematologic cancer	7.62e-05	0.000425	CcSEcCtD
Ivacaftor—Myalgia—Dexamethasone—hematologic cancer	7.62e-05	0.000425	CcSEcCtD
Ivacaftor—Dizziness—Carmustine—hematologic cancer	7.59e-05	0.000423	CcSEcCtD
Ivacaftor—Rash—Thalidomide—hematologic cancer	7.53e-05	0.00042	CcSEcCtD
Ivacaftor—Dermatitis—Thalidomide—hematologic cancer	7.52e-05	0.00042	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Doxorubicin—hematologic cancer	7.52e-05	0.000419	CcSEcCtD
Ivacaftor—Dizziness—Alitretinoin—hematologic cancer	7.51e-05	0.000419	CcSEcCtD
Ivacaftor—Diarrhoea—Vincristine—hematologic cancer	7.49e-05	0.000418	CcSEcCtD
Ivacaftor—Headache—Thalidomide—hematologic cancer	7.48e-05	0.000417	CcSEcCtD
Ivacaftor—Dizziness—Ifosfamide—hematologic cancer	7.43e-05	0.000414	CcSEcCtD
Ivacaftor—Nausea—Thiotepa—hematologic cancer	7.34e-05	0.000409	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	7.33e-05	0.000409	CcSEcCtD
Ivacaftor—Diarrhoea—Irinotecan—hematologic cancer	7.3e-05	0.000407	CcSEcCtD
Ivacaftor—Diarrhoea—Mitoxantrone—hematologic cancer	7.3e-05	0.000407	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Etoposide—hematologic cancer	7.25e-05	0.000405	CcSEcCtD
Ivacaftor—Infection—Betamethasone—hematologic cancer	7.25e-05	0.000405	CcSEcCtD
Ivacaftor—Infection—Dexamethasone—hematologic cancer	7.25e-05	0.000405	CcSEcCtD
Ivacaftor—Dizziness—Vincristine—hematologic cancer	7.24e-05	0.000404	CcSEcCtD
Ivacaftor—Rash—Carmustine—hematologic cancer	7.23e-05	0.000403	CcSEcCtD
Ivacaftor—Dermatitis—Carmustine—hematologic cancer	7.23e-05	0.000403	CcSEcCtD
Ivacaftor—Infestation NOS—Doxorubicin—hematologic cancer	7.21e-05	0.000402	CcSEcCtD
Ivacaftor—Infestation—Doxorubicin—hematologic cancer	7.21e-05	0.000402	CcSEcCtD
Ivacaftor—Headache—Carmustine—hematologic cancer	7.19e-05	0.000401	CcSEcCtD
Ivacaftor—Rash—Alitretinoin—hematologic cancer	7.17e-05	0.0004	CcSEcCtD
Ivacaftor—Nervous system disorder—Betamethasone—hematologic cancer	7.16e-05	0.000399	CcSEcCtD
Ivacaftor—Nervous system disorder—Dexamethasone—hematologic cancer	7.16e-05	0.000399	CcSEcCtD
Ivacaftor—Dermatitis—Alitretinoin—hematologic cancer	7.16e-05	0.000399	CcSEcCtD
Ivacaftor—Headache—Alitretinoin—hematologic cancer	7.12e-05	0.000397	CcSEcCtD
Ivacaftor—Diarrhoea—Gemcitabine—hematologic cancer	7.11e-05	0.000396	CcSEcCtD
Ivacaftor—Nausea—Thalidomide—hematologic cancer	7.09e-05	0.000396	CcSEcCtD
Ivacaftor—Rash—Ifosfamide—hematologic cancer	7.08e-05	0.000395	CcSEcCtD
Ivacaftor—Dermatitis—Ifosfamide—hematologic cancer	7.08e-05	0.000395	CcSEcCtD
Ivacaftor—Dizziness—Irinotecan—hematologic cancer	7.05e-05	0.000393	CcSEcCtD
Ivacaftor—Rhinitis—Epirubicin—hematologic cancer	7.02e-05	0.000391	CcSEcCtD
Ivacaftor—Abdominal pain—Etoposide—hematologic cancer	7.01e-05	0.000391	CcSEcCtD
Ivacaftor—Tinnitus—Methotrexate—hematologic cancer	6.97e-05	0.000389	CcSEcCtD
Ivacaftor—Rash—Vincristine—hematologic cancer	6.9e-05	0.000385	CcSEcCtD
Ivacaftor—Dermatitis—Vincristine—hematologic cancer	6.9e-05	0.000385	CcSEcCtD
Ivacaftor—Connective tissue disorder—Epirubicin—hematologic cancer	6.88e-05	0.000384	CcSEcCtD
Ivacaftor—Headache—Vincristine—hematologic cancer	6.86e-05	0.000383	CcSEcCtD
Ivacaftor—Nausea—Carmustine—hematologic cancer	6.81e-05	0.00038	CcSEcCtD
Ivacaftor—Nausea—Alitretinoin—hematologic cancer	6.75e-05	0.000376	CcSEcCtD
Ivacaftor—Mediastinal disorder—Methotrexate—hematologic cancer	6.74e-05	0.000376	CcSEcCtD
Ivacaftor—Rash—Mitoxantrone—hematologic cancer	6.72e-05	0.000375	CcSEcCtD
Ivacaftor—Rash—Irinotecan—hematologic cancer	6.72e-05	0.000375	CcSEcCtD
Ivacaftor—Dermatitis—Irinotecan—hematologic cancer	6.72e-05	0.000375	CcSEcCtD
Ivacaftor—Dermatitis—Mitoxantrone—hematologic cancer	6.72e-05	0.000375	CcSEcCtD
Ivacaftor—Headache—Mitoxantrone—hematologic cancer	6.68e-05	0.000373	CcSEcCtD
Ivacaftor—Headache—Irinotecan—hematologic cancer	6.68e-05	0.000373	CcSEcCtD
Ivacaftor—Nausea—Ifosfamide—hematologic cancer	6.67e-05	0.000372	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.65e-05	0.000371	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.65e-05	0.000371	CcSEcCtD
Ivacaftor—Arthralgia—Prednisone—hematologic cancer	6.63e-05	0.00037	CcSEcCtD
Ivacaftor—Myalgia—Prednisone—hematologic cancer	6.63e-05	0.00037	CcSEcCtD
Ivacaftor—Diarrhoea—Cisplatin—hematologic cancer	6.62e-05	0.000369	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.59e-05	0.000367	CcSEcCtD
Ivacaftor—Rash—Gemcitabine—hematologic cancer	6.55e-05	0.000365	CcSEcCtD
Ivacaftor—Dermatitis—Gemcitabine—hematologic cancer	6.54e-05	0.000365	CcSEcCtD
Ivacaftor—Tinnitus—Epirubicin—hematologic cancer	6.53e-05	0.000364	CcSEcCtD
Ivacaftor—Headache—Gemcitabine—hematologic cancer	6.51e-05	0.000363	CcSEcCtD
Ivacaftor—Nausea—Vincristine—hematologic cancer	6.5e-05	0.000363	CcSEcCtD
Ivacaftor—Rhinitis—Doxorubicin—hematologic cancer	6.49e-05	0.000362	CcSEcCtD
Ivacaftor—Connective tissue disorder—Doxorubicin—hematologic cancer	6.36e-05	0.000355	CcSEcCtD
Ivacaftor—Nausea—Irinotecan—hematologic cancer	6.33e-05	0.000353	CcSEcCtD
Ivacaftor—Nausea—Mitoxantrone—hematologic cancer	6.33e-05	0.000353	CcSEcCtD
Ivacaftor—Infection—Prednisone—hematologic cancer	6.32e-05	0.000352	CcSEcCtD
Ivacaftor—Mediastinal disorder—Epirubicin—hematologic cancer	6.31e-05	0.000352	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.3e-05	0.000352	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.3e-05	0.000352	CcSEcCtD
Ivacaftor—Nervous system disorder—Prednisone—hematologic cancer	6.23e-05	0.000348	CcSEcCtD
Ivacaftor—Skin disorder—Prednisone—hematologic cancer	6.18e-05	0.000344	CcSEcCtD
Ivacaftor—Nausea—Gemcitabine—hematologic cancer	6.17e-05	0.000344	CcSEcCtD
Ivacaftor—Rash—Cisplatin—hematologic cancer	6.11e-05	0.00034	CcSEcCtD
Ivacaftor—Dermatitis—Cisplatin—hematologic cancer	6.1e-05	0.00034	CcSEcCtD
Ivacaftor—Diarrhoea—Etoposide—hematologic cancer	6.07e-05	0.000339	CcSEcCtD
Ivacaftor—Tinnitus—Doxorubicin—hematologic cancer	6.04e-05	0.000337	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.97e-05	0.000333	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Betamethasone—hematologic cancer	5.97e-05	0.000333	CcSEcCtD
Ivacaftor—Dizziness—Etoposide—hematologic cancer	5.87e-05	0.000327	CcSEcCtD
Ivacaftor—Mediastinal disorder—Doxorubicin—hematologic cancer	5.84e-05	0.000326	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.79e-05	0.000323	CcSEcCtD
Ivacaftor—Dizziness—Prednisolone—hematologic cancer	5.79e-05	0.000323	CcSEcCtD
Ivacaftor—Abdominal pain—Betamethasone—hematologic cancer	5.77e-05	0.000322	CcSEcCtD
Ivacaftor—Abdominal pain—Dexamethasone—hematologic cancer	5.77e-05	0.000322	CcSEcCtD
Ivacaftor—Nausea—Cisplatin—hematologic cancer	5.75e-05	0.000321	CcSEcCtD
Ivacaftor—Rash—Etoposide—hematologic cancer	5.59e-05	0.000312	CcSEcCtD
Ivacaftor—Dermatitis—Etoposide—hematologic cancer	5.59e-05	0.000312	CcSEcCtD
Ivacaftor—Headache—Etoposide—hematologic cancer	5.56e-05	0.00031	CcSEcCtD
Ivacaftor—Arthralgia—Methotrexate—hematologic cancer	5.54e-05	0.000309	CcSEcCtD
Ivacaftor—Myalgia—Methotrexate—hematologic cancer	5.54e-05	0.000309	CcSEcCtD
Ivacaftor—Rash—Prednisolone—hematologic cancer	5.52e-05	0.000308	CcSEcCtD
Ivacaftor—Dermatitis—Prednisolone—hematologic cancer	5.51e-05	0.000307	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.5e-05	0.000307	CcSEcCtD
Ivacaftor—Headache—Prednisolone—hematologic cancer	5.48e-05	0.000306	CcSEcCtD
Ivacaftor—Dizziness—Triamcinolone—hematologic cancer	5.32e-05	0.000297	CcSEcCtD
Ivacaftor—Infection—Methotrexate—hematologic cancer	5.28e-05	0.000294	CcSEcCtD
Ivacaftor—Nausea—Etoposide—hematologic cancer	5.27e-05	0.000294	CcSEcCtD
Ivacaftor—Nervous system disorder—Methotrexate—hematologic cancer	5.21e-05	0.000291	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Prednisone—hematologic cancer	5.2e-05	0.00029	CcSEcCtD
Ivacaftor—Nausea—Prednisolone—hematologic cancer	5.2e-05	0.00029	CcSEcCtD
Ivacaftor—Myalgia—Epirubicin—hematologic cancer	5.19e-05	0.000289	CcSEcCtD
Ivacaftor—Arthralgia—Epirubicin—hematologic cancer	5.19e-05	0.000289	CcSEcCtD
Ivacaftor—Skin disorder—Methotrexate—hematologic cancer	5.16e-05	0.000288	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.15e-05	0.000287	CcSEcCtD
Ivacaftor—Rash—Triamcinolone—hematologic cancer	5.07e-05	0.000283	CcSEcCtD
Ivacaftor—Dermatitis—Triamcinolone—hematologic cancer	5.07e-05	0.000283	CcSEcCtD
Ivacaftor—Headache—Triamcinolone—hematologic cancer	5.04e-05	0.000281	CcSEcCtD
Ivacaftor—Abdominal pain—Prednisone—hematologic cancer	5.03e-05	0.00028	CcSEcCtD
Ivacaftor—Diarrhoea—Betamethasone—hematologic cancer	5e-05	0.000279	CcSEcCtD
Ivacaftor—Diarrhoea—Dexamethasone—hematologic cancer	5e-05	0.000279	CcSEcCtD
Ivacaftor—Infection—Epirubicin—hematologic cancer	4.94e-05	0.000276	CcSEcCtD
Ivacaftor—Nervous system disorder—Epirubicin—hematologic cancer	4.88e-05	0.000272	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.84e-05	0.00027	CcSEcCtD
Ivacaftor—Skin disorder—Epirubicin—hematologic cancer	4.83e-05	0.000269	CcSEcCtD
Ivacaftor—Dizziness—Betamethasone—hematologic cancer	4.83e-05	0.000269	CcSEcCtD
Ivacaftor—Dizziness—Dexamethasone—hematologic cancer	4.83e-05	0.000269	CcSEcCtD
Ivacaftor—Arthralgia—Doxorubicin—hematologic cancer	4.8e-05	0.000268	CcSEcCtD
Ivacaftor—Myalgia—Doxorubicin—hematologic cancer	4.8e-05	0.000268	CcSEcCtD
Ivacaftor—Nausea—Triamcinolone—hematologic cancer	4.78e-05	0.000267	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.77e-05	0.000266	CcSEcCtD
Ivacaftor—Rash—Dexamethasone—hematologic cancer	4.6e-05	0.000257	CcSEcCtD
Ivacaftor—Rash—Betamethasone—hematologic cancer	4.6e-05	0.000257	CcSEcCtD
Ivacaftor—Dermatitis—Dexamethasone—hematologic cancer	4.6e-05	0.000256	CcSEcCtD
Ivacaftor—Dermatitis—Betamethasone—hematologic cancer	4.6e-05	0.000256	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.59e-05	0.000256	CcSEcCtD
Ivacaftor—Headache—Dexamethasone—hematologic cancer	4.57e-05	0.000255	CcSEcCtD
Ivacaftor—Headache—Betamethasone—hematologic cancer	4.57e-05	0.000255	CcSEcCtD
Ivacaftor—Infection—Doxorubicin—hematologic cancer	4.57e-05	0.000255	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.53e-05	0.000253	CcSEcCtD
Ivacaftor—Nervous system disorder—Doxorubicin—hematologic cancer	4.51e-05	0.000252	CcSEcCtD
Ivacaftor—Skin disorder—Doxorubicin—hematologic cancer	4.47e-05	0.000249	CcSEcCtD
Ivacaftor—Diarrhoea—Prednisone—hematologic cancer	4.35e-05	0.000243	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Methotrexate—hematologic cancer	4.34e-05	0.000242	CcSEcCtD
Ivacaftor—Nausea—Betamethasone—hematologic cancer	4.34e-05	0.000242	CcSEcCtD
Ivacaftor—Nausea—Dexamethasone—hematologic cancer	4.34e-05	0.000242	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.29e-05	0.000239	CcSEcCtD
Ivacaftor—Dizziness—Prednisone—hematologic cancer	4.2e-05	0.000234	CcSEcCtD
Ivacaftor—Abdominal pain—Methotrexate—hematologic cancer	4.2e-05	0.000234	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.19e-05	0.000234	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Epirubicin—hematologic cancer	4.07e-05	0.000227	CcSEcCtD
Ivacaftor—Rash—Prednisone—hematologic cancer	4.01e-05	0.000224	CcSEcCtD
Ivacaftor—Dermatitis—Prednisone—hematologic cancer	4e-05	0.000223	CcSEcCtD
Ivacaftor—Headache—Prednisone—hematologic cancer	3.98e-05	0.000222	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.97e-05	0.000222	CcSEcCtD
Ivacaftor—Abdominal pain—Epirubicin—hematologic cancer	3.93e-05	0.000219	CcSEcCtD
Ivacaftor—Nausea—Prednisone—hematologic cancer	3.78e-05	0.000211	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.76e-05	0.00021	CcSEcCtD
Ivacaftor—Abdominal pain—Doxorubicin—hematologic cancer	3.64e-05	0.000203	CcSEcCtD
Ivacaftor—Diarrhoea—Methotrexate—hematologic cancer	3.64e-05	0.000203	CcSEcCtD
Ivacaftor—Dizziness—Methotrexate—hematologic cancer	3.51e-05	0.000196	CcSEcCtD
Ivacaftor—Diarrhoea—Epirubicin—hematologic cancer	3.4e-05	0.00019	CcSEcCtD
Ivacaftor—Rash—Methotrexate—hematologic cancer	3.35e-05	0.000187	CcSEcCtD
Ivacaftor—Dermatitis—Methotrexate—hematologic cancer	3.35e-05	0.000187	CcSEcCtD
Ivacaftor—Headache—Methotrexate—hematologic cancer	3.33e-05	0.000186	CcSEcCtD
Ivacaftor—Dizziness—Epirubicin—hematologic cancer	3.29e-05	0.000183	CcSEcCtD
Ivacaftor—Nausea—Methotrexate—hematologic cancer	3.16e-05	0.000176	CcSEcCtD
Ivacaftor—Diarrhoea—Doxorubicin—hematologic cancer	3.15e-05	0.000176	CcSEcCtD
Ivacaftor—Rash—Epirubicin—hematologic cancer	3.14e-05	0.000175	CcSEcCtD
Ivacaftor—Dermatitis—Epirubicin—hematologic cancer	3.13e-05	0.000175	CcSEcCtD
Ivacaftor—Headache—Epirubicin—hematologic cancer	3.12e-05	0.000174	CcSEcCtD
Ivacaftor—Dizziness—Doxorubicin—hematologic cancer	3.04e-05	0.00017	CcSEcCtD
Ivacaftor—Nausea—Epirubicin—hematologic cancer	2.95e-05	0.000165	CcSEcCtD
Ivacaftor—Rash—Doxorubicin—hematologic cancer	2.9e-05	0.000162	CcSEcCtD
Ivacaftor—Dermatitis—Doxorubicin—hematologic cancer	2.9e-05	0.000162	CcSEcCtD
Ivacaftor—Headache—Doxorubicin—hematologic cancer	2.88e-05	0.000161	CcSEcCtD
Ivacaftor—Nausea—Doxorubicin—hematologic cancer	2.73e-05	0.000152	CcSEcCtD
Ivacaftor—ALB—Hemostasis—CD44—hematologic cancer	1.49e-05	0.000426	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—ITGA4—hematologic cancer	1.49e-05	0.000426	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.47e-05	0.00042	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.47e-05	0.000418	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.46e-05	0.000417	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GBA—hematologic cancer	1.46e-05	0.000416	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SLC35B2—hematologic cancer	1.46e-05	0.000416	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.46e-05	0.000416	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—IL3—hematologic cancer	1.46e-05	0.000415	CbGpPWpGaD
Ivacaftor—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.45e-05	0.000413	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.45e-05	0.000413	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—IFNA1—hematologic cancer	1.45e-05	0.000412	CbGpPWpGaD
Ivacaftor—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.45e-05	0.000412	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.44e-05	0.00041	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.43e-05	0.000409	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PTPN1—hematologic cancer	1.43e-05	0.000408	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.43e-05	0.000406	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—RASGRP1—hematologic cancer	1.41e-05	0.000402	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—SYK—hematologic cancer	1.41e-05	0.0004	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CDA—hematologic cancer	1.38e-05	0.000392	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.37e-05	0.00039	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.37e-05	0.00039	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—IFNA2—hematologic cancer	1.35e-05	0.000384	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MTAP—hematologic cancer	1.33e-05	0.00038	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.33e-05	0.000379	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PC—hematologic cancer	1.32e-05	0.000377	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.3e-05	0.00037	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.28e-05	0.000365	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.28e-05	0.000364	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GBA—hematologic cancer	1.28e-05	0.000364	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.28e-05	0.000364	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—GRB2—hematologic cancer	1.27e-05	0.000361	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PDGFA—hematologic cancer	1.26e-05	0.00036	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	1.26e-05	0.00036	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.22e-05	0.000349	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GMPS—hematologic cancer	1.22e-05	0.000348	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PHYH—hematologic cancer	1.22e-05	0.000348	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—FTCD—hematologic cancer	1.22e-05	0.000348	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—ABL1—hematologic cancer	1.22e-05	0.000347	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—FHL2—hematologic cancer	1.19e-05	0.000339	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MTAP—hematologic cancer	1.17e-05	0.000333	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.17e-05	0.000333	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—AGRN—hematologic cancer	1.17e-05	0.000332	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.16e-05	0.000331	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—HGF—hematologic cancer	1.15e-05	0.000326	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.15e-05	0.000326	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—CSF2—hematologic cancer	1.13e-05	0.000323	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.12e-05	0.000319	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.11e-05	0.000318	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.11e-05	0.000317	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—IDH2—hematologic cancer	1.11e-05	0.000315	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HMMR—hematologic cancer	1.11e-05	0.000315	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—JAK1—hematologic cancer	1.09e-05	0.000311	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PRKCG—hematologic cancer	1.09e-05	0.000311	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.08e-05	0.000307	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.08e-05	0.000306	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.07e-05	0.000306	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.05e-05	0.0003	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.04e-05	0.000297	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—FHL2—hematologic cancer	1.04e-05	0.000297	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ARNTL—hematologic cancer	1.04e-05	0.000296	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.03e-05	0.000292	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—AGRN—hematologic cancer	1.02e-05	0.000291	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.02e-05	0.000291	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—IL2RA—hematologic cancer	1.02e-05	0.000291	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	1.01e-05	0.000289	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ACP5—hematologic cancer	1.01e-05	0.000288	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CA9—hematologic cancer	1.01e-05	0.000288	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NCOR2—hematologic cancer	9.99e-06	0.000284	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	9.98e-06	0.000284	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	9.87e-06	0.000281	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PDGFB—hematologic cancer	9.86e-06	0.000281	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—B3GAT1—hematologic cancer	9.78e-06	0.000278	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—DCK—hematologic cancer	9.78e-06	0.000278	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ASNS—hematologic cancer	9.78e-06	0.000278	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	9.72e-06	0.000277	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HMMR—hematologic cancer	9.69e-06	0.000276	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—IDH2—hematologic cancer	9.69e-06	0.000276	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—CDK2—hematologic cancer	9.56e-06	0.000272	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—IDH1—hematologic cancer	9.51e-06	0.000271	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTO1—hematologic cancer	9.41e-06	0.000268	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ABCC3—hematologic cancer	9.41e-06	0.000268	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—TXN—hematologic cancer	9.41e-06	0.000268	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	9.34e-06	0.000266	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HDC—hematologic cancer	9.27e-06	0.000264	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SPHK1—hematologic cancer	9.2e-06	0.000262	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	9.19e-06	0.000262	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—MAPK14—hematologic cancer	9.17e-06	0.000261	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ARNTL—hematologic cancer	9.11e-06	0.00026	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	9.06e-06	0.000258	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	8.94e-06	0.000255	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	8.92e-06	0.000254	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—FN1—hematologic cancer	8.89e-06	0.000253	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ACP5—hematologic cancer	8.86e-06	0.000252	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CA9—hematologic cancer	8.86e-06	0.000252	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—UGT1A1—hematologic cancer	8.84e-06	0.000252	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NCOR2—hematologic cancer	8.75e-06	0.000249	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SLC22A1—hematologic cancer	8.6e-06	0.000245	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CRABP1—hematologic cancer	8.6e-06	0.000245	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CG—hematologic cancer	8.51e-06	0.000242	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CDA—hematologic cancer	8.48e-06	0.000241	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ALOX5—hematologic cancer	8.38e-06	0.000239	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PTPN11—hematologic cancer	8.36e-06	0.000238	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—IDH1—hematologic cancer	8.33e-06	0.000237	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.33e-06	0.000237	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.26e-06	0.000235	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTO1—hematologic cancer	8.24e-06	0.000235	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ABCC3—hematologic cancer	8.24e-06	0.000235	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—TXN—hematologic cancer	8.24e-06	0.000235	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PC—hematologic cancer	8.16e-06	0.000232	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NUP98—hematologic cancer	8.12e-06	0.000231	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SPHK1—hematologic cancer	8.06e-06	0.00023	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—CREBBP—hematologic cancer	7.89e-06	0.000225	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NCOA3—hematologic cancer	7.88e-06	0.000224	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ADCY7—hematologic cancer	7.88e-06	0.000224	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.88e-06	0.000224	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GBA—hematologic cancer	7.88e-06	0.000224	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NUP214—hematologic cancer	7.83e-06	0.000223	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—UGT1A1—hematologic cancer	7.75e-06	0.000221	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.75e-06	0.000221	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	7.71e-06	0.00022	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ABCG2—hematologic cancer	7.67e-06	0.000218	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MTR—hematologic cancer	7.67e-06	0.000218	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	7.59e-06	0.000216	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SLC22A1—hematologic cancer	7.54e-06	0.000215	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CRABP1—hematologic cancer	7.54e-06	0.000215	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ENO2—hematologic cancer	7.52e-06	0.000214	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CD—hematologic cancer	7.48e-06	0.000213	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ALOX5—hematologic cancer	7.35e-06	0.000209	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.34e-06	0.000209	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTT1—hematologic cancer	7.29e-06	0.000208	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MTAP—hematologic cancer	7.21e-06	0.000205	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.18e-06	0.000205	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SDC1—hematologic cancer	7.13e-06	0.000203	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NUP98—hematologic cancer	7.11e-06	0.000203	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3R1—hematologic cancer	7.06e-06	0.000201	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ADCY7—hematologic cancer	6.91e-06	0.000197	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NCOA3—hematologic cancer	6.91e-06	0.000197	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—JAK2—hematologic cancer	6.86e-06	0.000196	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NUP214—hematologic cancer	6.86e-06	0.000195	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.83e-06	0.000194	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.81e-06	0.000194	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MTR—hematologic cancer	6.72e-06	0.000191	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ABCG2—hematologic cancer	6.72e-06	0.000191	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ENO2—hematologic cancer	6.59e-06	0.000188	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CB—hematologic cancer	6.52e-06	0.000186	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.43e-06	0.000183	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—FHL2—hematologic cancer	6.42e-06	0.000183	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTT1—hematologic cancer	6.39e-06	0.000182	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AGRN—hematologic cancer	6.3e-06	0.000179	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	6.3e-06	0.000179	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SDC1—hematologic cancer	6.25e-06	0.000178	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.2e-06	0.000177	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CD44—hematologic cancer	6.06e-06	0.000173	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NQO1—hematologic cancer	6.06e-06	0.000173	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—IL2—hematologic cancer	5.99e-06	0.000171	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.98e-06	0.00017	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—IDH2—hematologic cancer	5.97e-06	0.00017	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HMMR—hematologic cancer	5.97e-06	0.00017	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.93e-06	0.000169	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYCS—hematologic cancer	5.74e-06	0.000163	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HSP90AA1—hematologic cancer	5.7e-06	0.000162	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.61e-06	0.00016	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.6e-06	0.00016	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CA9—hematologic cancer	5.46e-06	0.000156	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ACP5—hematologic cancer	5.46e-06	0.000156	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.39e-06	0.000154	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—EP300—hematologic cancer	5.37e-06	0.000153	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NQO1—hematologic cancer	5.31e-06	0.000151	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CD44—hematologic cancer	5.31e-06	0.000151	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—SRC—hematologic cancer	5.22e-06	0.000149	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—IDH1—hematologic cancer	5.13e-06	0.000146	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.13e-06	0.000146	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—VEGFA—hematologic cancer	5.09e-06	0.000145	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.08e-06	0.000145	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.08e-06	0.000145	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—TXN—hematologic cancer	5.08e-06	0.000145	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTP1—hematologic cancer	5.06e-06	0.000144	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—NRAS—hematologic cancer	5.03e-06	0.000143	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYCS—hematologic cancer	5.03e-06	0.000143	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.99e-06	0.000142	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.97e-06	0.000142	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.89e-06	0.000139	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—MAPK3—hematologic cancer	4.81e-06	0.000137	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ABCB1—hematologic cancer	4.79e-06	0.000136	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.77e-06	0.000136	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—TGFB1—hematologic cancer	4.67e-06	0.000133	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NCOR1—hematologic cancer	4.65e-06	0.000132	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTM1—hematologic cancer	4.65e-06	0.000132	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.64e-06	0.000132	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.64e-06	0.000132	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.53e-06	0.000129	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTP1—hematologic cancer	4.43e-06	0.000126	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NUP98—hematologic cancer	4.38e-06	0.000125	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—KRAS—hematologic cancer	4.33e-06	0.000123	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.25e-06	0.000121	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.25e-06	0.000121	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NUP214—hematologic cancer	4.22e-06	0.00012	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MTR—hematologic cancer	4.14e-06	0.000118	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.14e-06	0.000118	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MTHFR—hematologic cancer	4.11e-06	0.000117	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NCOR1—hematologic cancer	4.07e-06	0.000116	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTM1—hematologic cancer	4.07e-06	0.000116	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ENO2—hematologic cancer	4.06e-06	0.000116	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CA—hematologic cancer	3.97e-06	0.000113	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.94e-06	0.000112	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SDC1—hematologic cancer	3.85e-06	0.00011	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—TP53—hematologic cancer	3.84e-06	0.00011	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—HRAS—hematologic cancer	3.68e-06	0.000105	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.62e-06	0.000103	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MTHFR—hematologic cancer	3.6e-06	0.000102	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CG—hematologic cancer	3.45e-06	9.82e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CD44—hematologic cancer	3.27e-06	9.32e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NQO1—hematologic cancer	3.27e-06	9.32e-05	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—AKT1—hematologic cancer	3.25e-06	9.25e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CREBBP—hematologic cancer	3.2e-06	9.11e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYCS—hematologic cancer	3.1e-06	8.82e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.08e-06	8.76e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CD—hematologic cancer	3.03e-06	8.64e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.02e-06	8.61e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3R1—hematologic cancer	2.86e-06	8.16e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CREBBP—hematologic cancer	2.8e-06	7.98e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.73e-06	7.77e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.66e-06	7.57e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CB—hematologic cancer	2.64e-06	7.53e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ALB—hematologic cancer	2.62e-06	7.47e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.58e-06	7.36e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.51e-06	7.15e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.51e-06	7.14e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.51e-06	7.14e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.32e-06	6.6e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PTEN—hematologic cancer	2.28e-06	6.51e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.22e-06	6.31e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—EP300—hematologic cancer	2.18e-06	6.2e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PTEN—hematologic cancer	2e-06	5.7e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—EP300—hematologic cancer	1.91e-06	5.44e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.86e-06	5.3e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.73e-06	4.92e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.64e-06	4.66e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ALB—hematologic cancer	1.62e-06	4.6e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CA—hematologic cancer	1.61e-06	4.59e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.55e-06	4.4e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.43e-06	4.06e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.41e-06	4.02e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—AKT1—hematologic cancer	1.32e-06	3.75e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PTEN—hematologic cancer	1.23e-06	3.51e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—EP300—hematologic cancer	1.18e-06	3.35e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—AKT1—hematologic cancer	1.15e-06	3.28e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.7e-07	2.48e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AKT1—hematologic cancer	7.11e-07	2.02e-05	CbGpPWpGaD
